Management of Olanzapine in Patients with New-Onset Diabetes
Assessment and Monitoring
- Patients taking olanzapine require greater monitoring because of the increased risk of type 2 diabetes associated with this medication 3, 4
- The American Diabetes Association recommends monitoring weight, glycemic control, and cholesterol levels regularly for patients on olanzapine 1, 2
Management Options
- Consider switching to an antipsychotic with a more benign metabolic profile, such as aripiprazole or ziprasidone, which tend to have fewer metabolic effects 3, 5
- If psychiatric symptoms are well-controlled, a complete switch to another antipsychotic may be appropriate, with a strength of evidence based on clinical guidelines 5
- Initiate metformin as first-line therapy for addressing metabolic side effects, starting at 500 mg once daily and increasing to 1 g twice daily as tolerated, as recommended by the American Association of Clinical Endocrinologists 5
Monitoring Requirements
- For patients who remain on olanzapine with diabetes, monitor weight, glycemic control, and cholesterol levels regularly, and incorporate monitoring of diabetes self-care activities into treatment goals 1, 2, 6
- Screen for complications of diabetes, with a focus on early detection and prevention, as recommended by the American Diabetes Association 3